Press release
Central Nervous System Drugs Market Competitive Insights, Opportunities & Strategies, Latest Trends, Key Driving Factors And Top Players - Biogen Inc., Johnson & Johnson, Hoffmann-La Roche Ltd
Central Nervous System Drugs Market
According to The Business Research Company's central nervous system drugs market report, the global central nervous system drugs market reached a value of nearly $125,277.9 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.6% since 2015. The market is expected to grow from $125,277.9 million in 2020 to $163,045.4 million in 2025 at a rate of 5.4%. The growth is mainly due to the increasing prevalence of psychological disorders which is expected to drive the demand for central nervous system drugs. The central nervous system (CNS) drugs market is expected to grow from $163,045.4 million in 2025 to $210,912.9 million in 2030 at a CAGR of 5.3%.
The market in the forecast period is expected to be supported by growing government for mental health awareness. While developing countries such as countries in North America and Western Europe already had a reasonable understanding and access to mental healthcare, and thus anti-depressants, this demand has increased multifold owing to the pandemic. For instance, the UK's government launched a Mental Health Recovery Action Plan on March 2021. The government is expected to spend £500 million to support people suffering from severe mental illnesses, including depression and PTSD, and those impacted by the pandemic. Countries such as Australia also invested about $2.3 billion for National Mental Health and Suicide Prevention Plan during the pandemic. This includes funds for increase in treatment for mental health diseases and adding up to 57 mental health treatment sites for adults, thus supporting the growth of the market.
View Our Buying Options For The Central Nervous System Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5332
The central nervous system drugs market is segmented -
• By Type: Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs
• By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies/ Drug Stores
• By Route Of Administration: Oral, Intravenous, Intranasal/ Inhalation
• By Drug Classification: Branded Drugs, Generic Drugs
• By Mode Of Purchase: Over-The-Counter Drugs, Prescription-Based Drugs
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the global central nervous system drugs market.
Major competitors in the central nervous system drugs market include Biogen Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Novartis AG, UCB.
See The Full Central Nervous System Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market
The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The CNS drugs include anesthetics, anticonvulsants, antiemetics, antiparkinsonian agents, CNS stimulants, analgesics, and sedatives. Neurological diseases such as Epilepsy, Parkinson and psychological indications such as depression, and dementia are generally treated through these CNS drugs.
The Table Of Content For The Central Nervous System Drugs Market Include:
1. Central Nervous System Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
7. Central Nervous System Drugs Market Characteristics
……
26. Global Central Nervous System Drugs Market Competitive Landscape
27. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
28. Market Background: Pharmaceutical Drugs Market
29. Central Nervous System Drugs Market Future Outlook and Potential Analysis
30. Appendix
The Business Research Company's "Global Central Nervous System Drugs Opportunities And Strategies Market Report - Forecast To 2030" is the most comprehensive report available in market, providing data and statistics from over 60 geographies analyzed in more than 2500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. Additionally, it evaluates the market's historic and projected growth and identifies significant trends and strategies that can be used to outperform the competitors in the sector.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Central Nervous System Drugs Market Competitive Insights, Opportunities & Strategies, Latest Trends, Key Driving Factors And Top Players - Biogen Inc., Johnson & Johnson, Hoffmann-La Roche Ltd here
News-ID: 2807055 • Views: 237
More Releases from The Business research company
Enterprise Governance, Risk And Compliance (EGRC) Market Market Forecast 2032: C …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Enterprise Governance, Risk And Compliance (EGRC) Market Size, Growth Rate, And Forecast
The global enterprise governance, risk and compliance (egrc) market size grew from $33.29 billion in 2022 to $38.26 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The Russia-Ukraine war disrupted the chances…
Single-Photon Emission Computed Tomography (SPECT) Market Trends, Top Companies, …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Employment Screening Services Market Size, Growth Rate, And Forecast
The global employment screening services market size grew from $4.46 billion in 2022 to $4.82 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from…
Emotion Detection and RecognitionMarket Analysis, Trends, Growth, Research And F …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Emotion Detection And Recognition Market Size, Growth Rate, And Forecast
The global emotion detection and recognition market size grew from $21.88 billion in 2022 to $25.32 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic…
Enterprise Asset Management Market 2023 - Size, Growth Rate, Top Companies, Regi …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Enterprise Asset Management Market Size, Growth Rate, And Forecast
The global enterprise asset management market size grew from $5.75 billion in 2022 to $6.39 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
